Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Straumann Holding AG ( (CH:STMN) ) has issued an announcement.
Straumann Group reported 2025 revenue of CHF 2.6 billion, representing 8.9% organic growth and confirming continued market-share gains across its global footprint. Performance was broad-based, with very strong growth in EMEA, solid improvement in North America, steady expansion in Asia-Pacific excluding China and double-digit gains in Latin America, while China remained weighed down by subdued patient traffic and procurement-related caution.
Profitability remained robust, with a core EBIT margin of 25.2% including currency effects and 26.5% at constant exchange rates, at the upper end of guidance, supported by efficiency gains and disciplined cost control. Growth was underpinned by major product launches such as the iEXCEL implant system, SIRIOS X3 intraoral scanner and the Straumann AXS cloud platform, as well as progress in transforming the orthodontics business via the ClearCorrect–Smartee partnership and extensive global training activities.
The group highlighted a strong performance culture, citing an employee engagement score of 80 that it links to its entrepreneurial, high-performance mindset. Reflecting disciplined capital allocation, the board proposed a 5% higher dividend of CHF 1.00 per share, and for 2026 the company guides to high single-digit organic revenue growth and a further core EBIT margin improvement despite ongoing market volatility.
The most recent analyst rating on (CH:STMN) stock is a Buy with a CHF120.00 price target. To see the full list of analyst forecasts on Straumann Holding AG stock, see the CH:STMN Stock Forecast page.
More about Straumann Holding AG
Straumann Holding AG, based in Basel, is a global dental medtech group specializing in implantology, orthodontics and digital dental solutions. Its portfolio spans premium and challenger implant brands, clear aligner systems and cloud-based digital workflows, serving dental professionals worldwide with a focus on innovation and service-oriented offerings.
Average Trading Volume: 400,219
Technical Sentiment Signal: Sell
Current Market Cap: CHF15.53B
For an in-depth examination of STMN stock, go to TipRanks’ Overview page.